Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMTSURO)

Drug Name	NiCord DMTSURO
Synonyms	NiCord (TN)

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Hematologic tumour	DIS9Y1NR	2B33.Y	Phase 3	[1]
------------------------------------------------------------------------------------

4 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Myelodysplastic syndrome	DISYHNUI	2A37	Phase 1/2	[2]
Acute lymphoblastic leukaemia	DIS87TGM	2A85	Phase 1/2	[2]
Hodgkin lymphoma	DISX2OUL	2B30	Phase 1/2	[2]
Sickle-cell anaemia	DIS5YNZB	3A51	Phase 1/2	[3]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02730299) Stem Cell Transplantation With NiCord (Omidubicel) vs Standard Umbilical Cord Blood in Patients With Leukemia, Lymphoma, and Myelodysplastic Syndrome (MDS). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	ClinicalTrials.gov (NCT01590628) Pilot Study Evaluating Safety & Efficacy of a DCBT: NiCord & UNM CBU to SCD Patients After Myeloablative Therapy. U.S. National Institutes of Health.